Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-19 of 19

Sort by

Sort Order Select

Journal Articles

ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer

Cancer Res (2021) 81 (7): 1704–1718.

https://doi.org/10.1158/0008-5472.CAN-20-2511

Published: 01 April 2021

View articletitled, ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer

Includes: Supplementary data

Journal Articles

Abstract 2452: Dysregulated expression of the human long noncoding RNA GHSROS may influence prostate cancer progression and resistance to docetaxel

Patrick B. Thomas, Penny L. Jeffery, Gahete D. Manuel, Eliza J. Whiteside, Michelle Maugham, Carina Walpole, Jennifer H. Gunter, Elizabeth D. Williams, Colleen C. Nelson, Adrian C. Herington, Raul M. Luque, Rakesh N. Veedu, Lisa K. Chopin, Inge Seim

Cancer Res (2018) 78 (13_Supplement): 2452.

https://doi.org/10.1158/1538-7445.AM2018-2452

Published: 01 July 2018

View articletitled, Abstract 2452: Dysregulated expression of the human long noncoding RNA GHSROS may influence prostate cancer progression and resistance to docetaxel

Journal Articles

Abstract 4909: Androgen targeted therapy induces ZEB1 expression and is associated with suppression of androgen signalling and therapy resistance

Katrina G. Sweeney, Nataly Stylianou, Gregor Tevz, Atefeh Taherianfard, Katrina Pirlo, Akanksha Upadhyaya, Ellca Ratther, Melanie Lehman, Martin Gleave, Jennifer Gunter, Elizabeth D. Williams, Colleen C. Nelson, Brett Hollier

Cancer Res (2017) 77 (13_Supplement): 4909.

https://doi.org/10.1158/1538-7445.AM2017-4909

Published: 01 July 2017

View articletitled, Abstract 4909: Androgen targeted therapy induces ZEB1 expression and is associated with suppression of androgen signalling and therapy resistance

Journal Articles

Abstract 2855: Monitoring tumor growth and oxygen distribution of prostate cancer xenografts in vivo using ultrasound and photoacoustic imaging

Qiuhua Hu, Ellca Ratther, Katrina Sweeney, Pamela J. Russell, Colleen C. Nelson, Brian W. Tse, Elizabeth D. Williams, Brett G. Hollier

Cancer Res (2017) 77 (13_Supplement): 2855.

https://doi.org/10.1158/1538-7445.AM2017-2855

Published: 01 July 2017

View articletitled, Abstract 2855: Monitoring tumor growth and oxygen distribution of prostate cancer xenografts in vivo using ultrasound and photoacoustic imaging

Journal Articles

Abstract 851: Reversion of epithelial to mesenchymal transition under androgen deprived conditions promotes chemoresistance in prostate cancer

Akanksha Upadhyaya, Nataly Stylianou, Anthony M. Davies, Sarah-Louise Ryan, Brett G. Hollier, Elizabeth D. Williams

Cancer Res (2017) 77 (13_Supplement): 851.

https://doi.org/10.1158/1538-7445.AM2017-851

Published: 01 July 2017

View articletitled, Abstract 851: Reversion of epithelial to mesenchymal transition under androgen deprived conditions promotes chemoresistance in prostate cancer

Journal Articles

Abstract 818: Unravelling the role of androgen targeted therapies in epithelial plasticity during prostate cancer progression

Ellca Ratther, Katrina G. Sweeney, Nataly Stylianou, Qiuhua Hu, Gregor Tevz, Colleen C. Nelson, Elizabeth D. Williams, Brett G. Hollier

Cancer Res (2017) 77 (13_Supplement): 818.

https://doi.org/10.1158/1538-7445.AM2017-818

Published: 01 July 2017

View articletitled, Abstract 818: Unravelling the role of androgen targeted therapies in epithelial plasticity during prostate cancer progression

Journal Articles

MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2

Cancer Res (2017) 77 (4): 1021–1034.

https://doi.org/10.1158/0008-5472.CAN-16-2529

Published: 14 February 2017

View articletitled, MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2

Includes: Supplementary data

Journal Articles

Abstract 4282: High content multiparametric functional screen for regulators of epithelial-mesenchymal transition identifies genes associated with chemoresistance

Elizabeth D. Williams, Nur Akmarina Said, Cathryn M. Gould, Erik W. Thompson, Kaylene J. Simpson

Cancer Res (2014) 74 (19_Supplement): 4282.

https://doi.org/10.1158/1538-7445.AM2014-4282

Published: 01 October 2014

View articletitled, Abstract 4282: High content multiparametric functional screen for regulators of epithelial-mesenchymal transition identifies genes associated with chemoresistance

Journal Articles

ATF3 Suppresses Metastasis of Bladder Cancer by Regulating Gelsolin-Mediated Remodeling of the Actin Cytoskeleton

Xiangliang Yuan, Liang Yu, Junhua Li, Guohua Xie, Tingting Rong, Liang Zhang, Jianhua Chen, Qiaohong Meng, Aaron T. Irving, Die Wang, Elizabeth D. Williams, Jun-Ping Liu, Anthony J. Sadler, Bryan R.G. Williams, Lisong Shen, Dakang Xu

Cancer Res (2013) 73 (12): 3625–3637.

https://doi.org/10.1158/0008-5472.CAN-12-3879

Published: 13 June 2013

View articletitled, ATF3 Suppresses Metastasis of Bladder Cancer by Regulating Gelsolin-Mediated Remodeling of the Actin Cytoskeleton

Includes: Supplementary data

Journal Articles

Abstract 5299: VEGF receptor-3 interacts with PI3K directly to regulate lymphangiogenesis

Sanja Coso, Yiping Zeng, Kenneth Opeskin, Elizabeth D. Williams

Cancer Res (2012) 72 (8_Supplement): 5299.

https://doi.org/10.1158/1538-7445.AM2012-5299

Published: 15 April 2012

View articletitled, Abstract 5299: VEGF receptor-3 interacts with PI3K directly to regulate lymphangiogenesis

Journal Articles

Abstract 469: CD151 and cell motility in prostate cancer

Sujitra Detchokul, Michael W. Parker, Elizabeth D. Williams, Olivia M. Herdiman, Melissa Davis, Kelvin Kee, Damien M. Bolton, Albert G. Frauman

Cancer Res (2012) 72 (8_Supplement): 469.

https://doi.org/10.1158/1538-7445.AM2012-469

Published: 15 April 2012

View articletitled, Abstract 469: CD151 and cell motility in prostate cancer

Journal Articles

Abstract 3711: Discovery of new therapeutic strategies for rare cancers with defined genetic lesions

Lauren T. Kerr, Sophie Young, Elizabeth D. Williams, David Thomas, Terrance G. Johns

Cancer Res (2012) 72 (8_Supplement): 3711.

https://doi.org/10.1158/1538-7445.AM2012-3711

Published: 15 April 2012

View articletitled, Abstract 3711: Discovery of new therapeutic strategies for rare cancers with defined genetic lesions

Journal Articles

Abstract 3484: Murine and human lymphatic endothelial cells show similar marker profiles and migratory properties

Sanja Coso, Elizabeth D. Williams

Cancer Res (2011) 71 (8_Supplement): 3484.

https://doi.org/10.1158/1538-7445.AM2011-3484

Published: 15 April 2011

View articletitled, Abstract 3484: Murine and human lymphatic endothelial cells show similar marker profiles and migratory properties

Journal Articles

Mesenchymal-to-Epithelial Transition Facilitates Bladder Cancer Metastasis: Role of Fibroblast Growth Factor Receptor-2

Christine L. Chaffer, Janelle P. Brennan, John L. Slavin, Tony Blick, Erik W. Thompson, Elizabeth D. Williams

Cancer Res (2006) 66 (23): 11271–11278.

https://doi.org/10.1158/0008-5472.CAN-06-2044

Published: 04 December 2006

View articletitled, Mesenchymal-to-Epithelial Transition Facilitates Bladder Cancer Metastasis: Role of Fibroblast Growth Factor Receptor-2

Includes: Supplementary data

Journal Articles

Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis

Yiping Zeng, Kenneth Opeskin, Jeremy Goad, Elizabeth D. Williams

Cancer Res (2006) 66 (19): 9566–9575.

https://doi.org/10.1158/0008-5472.CAN-06-1488

Published: 03 October 2006

View articletitled, Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis

Includes: Supplementary data

Journal Articles

Inhibin alpha subunit activates VEGF-C and promotes lymphangigenesis in advanced prostate cancer

Preetika Balanathan, Elizabeth D. Williams, Hong Wang, Gail Risbridger

Cancer Res (2006) 66 (8_Supplement): 244–245.

Published: 15 April 2006

View articletitled, Inhibin alpha subunit activates VEGF-C and promotes lymphangigenesis in advanced prostate cancer

Journal Articles

Mesenchymal to epithelial transition in the establishment of secondary tumors: Insights from a bladder carcinoma progression series

Elizabeth D. Williams, Christine L. Chaffer, Samantha R. Oakes, Christopher J. Ormandy, Tony Blick, Erik W. Thompson

Cancer Res (2006) 66 (8_Supplement): 650.

Published: 15 April 2006

View articletitled, Mesenchymal to epithelial transition in the establishment of secondary tumors: Insights from a bladder carcinoma progression series

Journal Articles

Characterization of a novel in vivo androgen dependent prostate cancer xenograft, BM18, derived from a human bone metastasis biopsy

Daniel R. McCulloch, Kenneth Opeskin, Erik W. Thompson, Elizabeth D. Williams

Cancer Res (2005) 65 (9_Supplement): 460–461.

Published: 01 May 2005

View articletitled, Characterization of a novel in vivo androgen dependent prostate cancer xenograft, BM18, derived from a human bone metastasis biopsy

Journal Articles

Bone microenvironment is required for osteoinductive effect of new human prostate cancer xenograft BM18.

Elizabeth D. Williams, Courtney Thornely, Kenneth Opeskin, Erik W. Thompson

Cancer Res (2004) 64 (7_Supplement): 772.

Published: 01 April 2004

View articletitled, Bone microenvironment is required for osteoinductive effect of new human prostate cancer xenograft BM18.

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer

Abstract 2452: Dysregulated expression of the human long noncoding RNA GHSROS may influence prostate cancer progression and resistance to docetaxel

Abstract 4909: Androgen targeted therapy induces ZEB1 expression and is associated with suppression of androgen signalling and therapy resistance

Abstract 2855: Monitoring tumor growth and oxygen distribution of prostate cancer xenografts in vivo using ultrasound and photoacoustic imaging

Abstract 851: Reversion of epithelial to mesenchymal transition under androgen deprived conditions promotes chemoresistance in prostate cancer

Abstract 818: Unravelling the role of androgen targeted therapies in epithelial plasticity during prostate cancer progression

MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2

Abstract 4282: High content multiparametric functional screen for regulators of epithelial-mesenchymal transition identifies genes associated with chemoresistance

ATF3 Suppresses Metastasis of Bladder Cancer by Regulating Gelsolin-Mediated Remodeling of the Actin Cytoskeleton

Abstract 5299: VEGF receptor-3 interacts with PI3K directly to regulate lymphangiogenesis

Abstract 469: CD151 and cell motility in prostate cancer

Abstract 3711: Discovery of new therapeutic strategies for rare cancers with defined genetic lesions

Abstract 3484: Murine and human lymphatic endothelial cells show similar marker profiles and migratory properties

Mesenchymal-to-Epithelial Transition Facilitates Bladder Cancer Metastasis: Role of Fibroblast Growth Factor Receptor-2

Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis

Inhibin alpha subunit activates VEGF-C and promotes lymphangigenesis in advanced prostate cancer

Mesenchymal to epithelial transition in the establishment of secondary tumors: Insights from a bladder carcinoma progression series

Characterization of a novel in vivo androgen dependent prostate cancer xenograft, BM18, derived from a human bone metastasis biopsy

Bone microenvironment is required for osteoinductive effect of new human prostate cancer xenograft BM18.

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only